Alameda, CA, July 25, 2006 — Michael D. West, Chairman, President and Chief Scientific Officer of Advanced Cell Technology, Inc. (OTCBB: ACTC) will participate at the California Institute of Regenerative Medicine’s (CIRM) Roundtable Discussion on Industry and Stem Cells in California: Fostering R & D, on Tuesday, July 25, 2006. CIRM is the state agency responsible for disbursing $3 billion for stem cell research to California’s universities and research institutions. The discussion is part of the CIRM’s scientific strategic planning process and will begin at 1:00 p.m. at the Robertson Auditorium, Mission Bay Conference Center at UCSF, San Francisco, CA.
“We are enthusiastic supporters of Governor Schwarzenegger’s decision to advance regenerative medicine,” said Michael D. West, Chairman, President, and Chief Scientific Officer of Advanced Cell Technology. “We look forward to helping communicate the needs of the biotechnology industry to CIRM and identifying means to accelerate the translation of this important science into lifesaving therapy.”
Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com.
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company’s periodic reports, including the report on Form 10-QSB for the quarter ended March 31, 2006.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Media Relations: Noelle Gambill
Chad Griffin Consulting
(805) 252-3922
Investor Relations: James Carbonara
The Investor Relations Group
(212) 825-3210
Noelle Gambill
(805) 252-3922